Publication | Open Access
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma
261
Citations
33
References
2019
Year
The IMWG flow MRD-negative response criterion is highly applicable and sensitive to evaluate treatment efficacy in MM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1